205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
3.96%
Net income growth under 50% of ADI's 10.07%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
93.86%
Lower 'other non-cash' growth vs. ADI's 500.00%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
30.10%
Some CFO growth while ADI is negative at -18.35%. John Neff would note a short-term liquidity lead over the competitor.
-31.10%
Negative yoy CapEx while ADI is 9.22%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
12.71%
Purchases well above ADI's 2.25%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
101.13%
Proceeds from sales/maturities above 1.5x ADI's 32.95%. David Dodd would confirm if the firm is capitalizing on strong valuations or freeing liquidity for expansions.
No Data
No Data available this quarter, please select a different quarter.
32.40%
Investing outflow well above ADI's 42.11%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
-12.82%
Negative yoy issuance while ADI is 1166.67%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.